Aicheck Biotech, Inc.   
$\%$ Dylan Wu   
IVD Senior Consultant   
Shanghai Sungo Management Consulting Co., Ltd. 14th Floor, 1500# Century Avenue   
Shanghai, 200122, China   
Re: K242498 Trade/Device Name: Pocguide Multi-Drug Test Panel, Pocguide Multi-Drug Test Panel OTC Regulation Number: 21 CFR 862.3100 Regulation Name: Amphetamine test system Regulatory Class: Class II Product Code: NFT, NGL, PTH, NFV, NFY, PTG, NGG, NGM, QAW, NFW Dated: August 22, 2024 Received: August 22, 2024   
Dear Dylan Wu:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safetyreporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical  
devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn   
(https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).   
Sincerely,   
Joseph A. Digitally signed by Joseph A. Kotarek -S   
Kotarek -S Date: 2024.10.0110:15:07 -04'00'   
Joseph Kotarek   
Branch Chief for Toxicology   
Division of Chemistry and Toxicology Devices   
OHT7: Office of In Vitro Diagnostics   
Office of Product Evaluation and Quality   
Center for Devices and Radiological Health

Enclosure

<table><tr><td>DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Indications for Use</td><td>Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2023</td></tr></table>

<table><tr><td>Indications for Use</td><td>Expiralion Date: 06/30/2023 See PRA Statement below.</td></tr><tr><td>510(k) Number (if known) K242498 Device Name</td></tr><tr><td>Pocguide Multi-Drug Test Panel OTC Pocguide Multi-Drug Test Panel Indications for Use (Describe)</td></tr><tr><td>PulDrTestPaneOTs petiivindi ateal ooraphissyr iv and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2-ethylidene-1,5- dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxy-methamphetamine, Morphine, Methadone,</td></tr><tr><td>Oxycodone, Phencyclidine, Nortriptyline and Marijuana in human urine at the cutoff concentrations of: Drug ( Identifier) Cut-off level</td></tr><tr><td>Amphetamine (AMP) 1000 ng/mL or 500 ng/mL Buprenorphine (BUP) 10 ng/mL</td></tr><tr><td>Secobarbital (BAR) 300 ng/mL Oxazepam (BZO) 300 ng/mL</td></tr><tr><td>Benzoylecognine (COC) 300 ng/mL or 150 ng/mL 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) 300 ng/mL</td></tr></table>

For over-the-counter use. For in vitro diagnostic use only

Pocguide Multi-Drug Test Panel is competitive binding, lateral flow immunochromatographic assay for qualitative   
simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2-ethylidene-1,5-dim   
3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxy-methamphetamine, Morphine, Methadone, Oxycodo   
Phencyclidine, Nortriptyline and Marijuana in human urine at the cutoff concentrations of:   
Drug ( Identifier) Cut-off level   
Amphetamine (AMP) $1 0 0 0 ~ \mathrm { { n g / m L } }$ or $5 0 0 ~ \mathrm { { n g / m L } }$   
Buprenorphine (BUP) $1 0 ~ \mathrm { n g / m L }$   
Secobarbital (BAR) $3 0 0 ~ \mathrm { { n g / m L } }$   
Oxazepam (BZO) $3 0 0 ~ \mathrm { { n g / m L } }$   
Benzoylecognine (COC) $3 0 0 ~ \mathrm { { n g / m L } }$ or $1 5 0 ~ \mathrm { { n g / m L } }$   
2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) 300 ng/mL   
Methamphetamine (MET) $1 0 0 0 ~ \mathrm { { n g / m L } }$ or $5 0 0 ~ \mathrm { { n g / m L } }$   
Methylenedioxymethamphetamine (MDMA) 500 ng/mL   
Morphine (OPI2000/MOP300) 2000 ng/mL or $3 0 0 ~ \mathrm { { n g / m L } }$   
Methadone (MTD) 300 ng/mL   
Oxycodone (OXY) 100 ng/mL

<table><tr><td>Phencyclidine (PCP)</td><td>25 ng/mL</td></tr><tr><td>Nortriptyline (TCA)</td><td>1000 ng/mL</td></tr><tr><td>Marijuana (THC)</td><td>50 ng/mL</td></tr><tr><td>The single or multi-test panels can consist of up to the above listed analytes in any combination.</td><td></td></tr><tr><td>Th k </td><td></td></tr><tr><td>ttguiepretiuheCrat alu</td><td></td></tr><tr><td>be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result.</td><td></td></tr><tr><td>The tests providenly  preliminary rslt. more peciilternativehemialmethod must beuse tai </td><td></td></tr><tr><td>confirmed positive result. Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass</td><td></td></tr><tr><td>Spectrometry (LC-MS), and theirtandem mass-spectromeerversions are the prefee confirmatory methods.aru</td><td></td></tr><tr><td></td><td></td></tr><tr><td>ceat ndj houl plbuee reu prticular heva</td><td></td></tr></table>

For in vitro diagnostic use only

Type of Use (Select one or both, as applicable)

Prescription Use (Part 21 CFR 801 Subpart D)

# CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

# \*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.\*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number.”

# 510(K) Summary

# K242498

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement   
by 21 CFR 807.92   
Date prepared: 15th, Aug 2024

# 1 Submitter’s Information

Name: Aicheck Biotech, Inc.   
Address: 17701 Cowan Ste 230, Irvine, CA, USA, 92614 Contact Person: Lisa Liu   
Title: Manager of the quality department   
Tel: +86-571-89055299   
Email: ra.rep@aichek.com

# 2 Official Contact Person Information

Primary contact: Mr. Dylan Wu   
Shanghai SUNGO Management Consulting Co., Ltd.   
Room 1401, Dongfang Building, 1500# Century Ave., Shanghai 200122, China Tel: +86-18616797137   
Email: haiyang.wu@sungoglobal.com   
Secondary contact: Mr. Raymond Luo   
Room 1401, Dongfang Building, 1500# Century Ave., Shanghai 200122, China Tel: +86-21-68828050   
Email: zxfda@sungoglobal.com

# 3 Subject Device

# 3.1 Trade Name and Regulatory Information

PocguideTM Multi-Drug Test Panel PocguideTM Multi-Drug Test Panel OTC

# 3.2 Regulatory Information

<table><tr><td rowspan=1 colspan=1>Drug (Identifier)</td><td rowspan=1 colspan=1>Code (s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>Amphetamine (AMP)</td><td rowspan=1 colspan=1>NFT</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3100Amphetamine Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine (BUP)</td><td rowspan=1 colspan=1>NGL</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3650Opiate Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Secobarbital (BAR)</td><td rowspan=1 colspan=1>PTH</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3150Barbiturate test system</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Oxazepam (BZO)</td><td rowspan=1 colspan=1>NFV</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3170Benzodiazepine test system</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Benzoylecognine (COC)</td><td rowspan=1 colspan=1>NFY</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR  862.3250Cocaine and Cocaine Metabolites Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)</td><td rowspan=1 colspan=1>PTG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21CFR § 862.3620Methadone Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine (MET)</td><td rowspan=1 colspan=1>NGG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3610Methamphetamine Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr></table>

Aicheck Biotech, Inc. 17701 Cowan Ste 230, Irvine, CA, USA, 92614   

<table><tr><td rowspan=1 colspan=1>Drug (Identifier)</td><td rowspan=1 colspan=1>Code (s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>Methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>NGG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR  862.3610Methamphetamine Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Morphine (OPI/MOP)</td><td rowspan=1 colspan=1>NGL</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3650Opiate Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Methadone (MTD)</td><td rowspan=1 colspan=1>PTG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21CFR § 862.3620Methadone Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Oxycodone (OXY)</td><td rowspan=1 colspan=1>NGL</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR  862.3650Opiate Test System</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine (PCP)</td><td rowspan=1 colspan=1>NGM</td><td rowspan=1 colspan=1>Unclassified</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Nortriptyline (TCA)</td><td rowspan=1 colspan=1>QAW</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR  862.3910Tricyclic antidepressant drugs test system</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr><tr><td rowspan=1 colspan=1>Marijuana (THC)</td><td rowspan=1 colspan=1>NFW</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3870Cannabinoid test system</td><td rowspan=1 colspan=1>ClinicalToxicology</td></tr></table>

# 4 Predicate device

K202567

Wondfo T-Dip® Multi-Drug Urine Test Panel Wondfo T-Dip® Multi-Drug Urine Test Panel Rx

# 5 Indications for use/Intended use

PocguideTM Multi-Drug Test Panel is competitive binding, lateral flow immunochromatographic assay for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2-ethylidene-1,5- dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxy-methamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline and Marijuana in human urine at the cutoff concentrations of:

<table><tr><td rowspan=1 colspan=1>Drug (Identifier)</td><td rowspan=1 colspan=1>Cut-off level</td></tr><tr><td rowspan=1 colspan=1>Amphetamine (AMP)</td><td rowspan=1 colspan=1>1000 ng/mL or 500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine (BUP)</td><td rowspan=1 colspan=1>10 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Secobarbital (BAR)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Oxazepam (BZO)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Benzoylecognine (COC)</td><td rowspan=1 colspan=1>300 ng/mL or 150 ng/mL</td></tr><tr><td rowspan=1 colspan=1>2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine (MET)</td><td rowspan=1 colspan=1>1000 ng/mL or 500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methylenedioxymethamphetamine (MDMA)</td><td rowspan=1 colspan=1>500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Morphine (OPI2000/MOP300)</td><td rowspan=1 colspan=1>2000 ng/mL or 300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methadone (MTD)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Oxycodone (OXY)</td><td rowspan=1 colspan=1>100 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine (PCP)</td><td rowspan=1 colspan=1>25 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline (TCA)</td><td rowspan=1 colspan=1>1000 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Marijuana (THC)</td><td rowspan=1 colspan=1>50 ng/mL</td></tr></table>

The single or multi-test panels can consist of up to the above listed analytes in any combination.

The tests may yield positive results for the prescription drugs when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminary positive result. The tests provide only a preliminary result. A more specific alternative chemical method must be used to obtain a confirmed positive result. Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and their tandem mass-spectrometer versions are the preferred confirmatory methods. Careful consideration and judgment should be applied to any drugs of abuse screen test result, particularly when evaluating preliminary positive results.   
For in vitro diagnostic use only.

PocguideTM Multi-Drug Test Panel OTC is competitive binding, lateral flow immunochromatographic assay for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2- ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxy-methamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, Nortriptyline and Marijuana in human urine at the cutoff concentrations of:

<table><tr><td rowspan=1 colspan=1>Drug (Identifier)</td><td rowspan=1 colspan=1>Cut-off level</td></tr><tr><td rowspan=1 colspan=1>Amphetamine (AMP)</td><td rowspan=1 colspan=1>1000 ng/mL or 500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine (BUP)</td><td rowspan=1 colspan=1>10 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Secobarbital (BAR)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Oxazepam (BZO)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Benzoylecognine (COC)</td><td rowspan=1 colspan=1>300 ng/mL or 150 ng/mL</td></tr><tr><td rowspan=1 colspan=1>2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine (MET)</td><td rowspan=1 colspan=1>1000 ng/mL or 500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methylenedioxymethamphetamine (MDMA)</td><td rowspan=1 colspan=1>500 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Morphine (OPI2000/MOP300)</td><td rowspan=1 colspan=1>2000 ng/mL or 300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Methadone (MTD)</td><td rowspan=1 colspan=1>300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Oxycodone (OXY)</td><td rowspan=1 colspan=1>100 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine (PCP)</td><td rowspan=1 colspan=1>25 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline (TCA)</td><td rowspan=1 colspan=1>1000 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Marijuana (THC)</td><td rowspan=1 colspan=1>50 ng/mL</td></tr></table>

The single or multi-test panels can consist of up to the above listed analytes in any combination.

The tests provide only a preliminary result. A more specific alternative chemical method must be used to obtain a confirmed positive result. Gas Chromatography-Mass Spectrometry (GC-MS), Liquid Chromatography-Mass Spectrometry (LC-MS), and their tandem mass-spectrometer versions are the preferred confirmatory methods. Careful consideration and judgment should be applied to any drugs of abuse screen test result, particularly when evaluating preliminary positive results.

For over-the-counter (OTC) use. For in vitro diagnostic use only.

# 6 Device Description

PocguideTM Multi-Drug Test Panel and PocguideTM Multi-Drug Test Panel OTC are immunochromatographic assays that use a lateral flow system for the qualitative detection of single or multiple drugs in human urine at or above the cut-off levels as indicated. The products are single use in vitro diagnostic devices.   
This device is a dipcard format in which the test strips are integrated into the plastic dipcard. After removing the cap of the dipcard, the absorbent end of the test strips is exposed and can be in direct contact with the urine sample. The device is in a ready-to-use format and no longer requires assembly before use.

# 7 Principle of Operation

PocguideTM Multi-Drug Test Panel is a competitive immunoassay that is used to screen for the presence of drugs of abuse in urine. It is chromatographic absorbent device in which drugs or drug metabolites in a sample competitively combined to a limited number of antibody-dye conjugate binding sites. When the absorbent end of the test device is immersed into the urine sample, the urine is absorbed into the device by capillary action, mixes with the antibodydye conjugate, and flows across the pre-coated membrane.

When sample drug levels are at or above the target cutoff (the detection sensitivity of the test), the drug in the sample binds to the antibody-dye conjugate preventing the antibody-dye conjugate from binding to the drug-protein pre-coated in the test region (T). This prevents the development of a distinct colored band in the test region indicating a potentially positive result.

When sample drug levels are zero or below the target cutoff, antibody-dye conjugate binds to the drug-protein precoated in the test region (T) of the device. This produces a colored test line that, regardless of its intensity, indicates a negative result.

To serve as a procedural control, a colored line will always appear at the control region (C) indicating that proper volume of specimen has been added and membrane wicking has occurred.

# 8 Substantial Equivalence Information

# 8.1 Technological characteristics

Table 1 Comparison of Technological characteristics   

<table><tr><td rowspan=1 colspan=2>EY</td><td></td><td></td><td></td></tr><tr><td rowspan=1 colspan=2>Device</td><td rowspan=1 colspan=2>Proposed Device</td><td rowspan=1 colspan=1>Predicate Device</td></tr><tr><td rowspan=1 colspan=2>510K number</td><td rowspan=1 colspan=2>K242498</td><td rowspan=1 colspan=1>K202567</td></tr><tr><td rowspan=1 colspan=2>Device name</td><td rowspan=1 colspan=2>Pocguide™M Multi-Drug Test PanelPocguide™M Multi-Drug Test Panel OTC</td><td rowspan=1 colspan=1>Wondfo T-Dip® Multi-Drug Urine Test PanelWondfo T-Dip® Multi-Drug Urine Test Panel Rx</td></tr><tr><td rowspan=1 colspan=2>Indication (s) foruse</td><td rowspan=1 colspan=2>For the qualitative determination of Amphetamine,Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine,Methamphetamine, Methylenedioxymethamphetamine,Morphine, Methadone, Oxycodone, Phencyclidine,Propoxyphene, Nortriptyline and Marijuana in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Methodology</td><td rowspan=1 colspan=2>Competitive binding, lateral flow immunochromatographicassay based on antigen-antibody reaction</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Type of Test</td><td rowspan=1 colspan=2>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=2>Specimen Type</td><td rowspan=1 colspan=2>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=15 colspan=2>Target Drugand CutoffValue</td><td rowspan=1 colspan=1>Target Drug</td><td rowspan=1 colspan=1>Cutoff (ng/mL)</td><td rowspan=15 colspan=1>The number of drugs detected are different, thepredicate device also includes Propoxyphene(PPX) 300 ng/mL</td></tr><tr><td rowspan=1 colspan=1>Amphetamine (AMP)</td><td rowspan=1 colspan=1>1000 or 500</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine (BUP)</td><td rowspan=1 colspan=1>10</td></tr><tr><td rowspan=1 colspan=1>Secobarbital (BAR)</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Oxazepam (BZO)</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Benzoylecognine (COC)</td><td rowspan=1 colspan=1>300 or 150</td></tr><tr><td rowspan=1 colspan=1>2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP)</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine (MET)</td><td rowspan=1 colspan=1>1000 or 500</td></tr><tr><td rowspan=1 colspan=1>Methylenedioxymethamphetamine(MDMA)</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>Morphine (OPI2000/MOP300)</td><td rowspan=1 colspan=1>2000 or 300</td></tr><tr><td rowspan=1 colspan=1>Methadone (MTD)</td><td rowspan=1 colspan=1>300</td></tr><tr><td rowspan=1 colspan=1>Oxycodone (OXY)</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>Phencyclidine (PCP)</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Nortriptyline (TCA)</td><td rowspan=1 colspan=1>1000</td></tr><tr><td rowspan=1 colspan=1>Marijuana (THC)</td><td rowspan=1 colspan=1>50</td></tr><tr><td rowspan=1 colspan=2>Configurations</td><td rowspan=1 colspan=2>Test Panel</td><td rowspan=1 colspan=1>Same</td></tr></table>

# 9 Summary of Non-Clinical Testing

# 9.1 Analytical performance

# a Precision / Reproducibility

Precision studies were carried out for samples with concentrations of - ${ \cdot } 1 0 0 \%$ cutoff, - $7 5 \%$ cutoff, $- 5 0 \%$ cutoff, - $- 2 5 \%$ cutoff, cutoff, $+ 2 5 \%$ cutoff, $+ 5 0 \%$ cutoff, $+ 7 5 \%$ cutoff and $+ 1 0 0 \%$ cutoff. Samples with concentration of - ${ \cdot } 1 0 0 \%$ cutoff were drug-free urines samples. Other samples were prepared by spiking target drug in drug-free urines samples. Each drug concentration was confirmed by LC/MS. All sample aliquots were tested in a blinded fashion. For each concentration, tests were performed in 2 runs per day for 25 days using 3 lots of test panels. The results obtained are summarized in Table 2.

<table><tr><td rowspan=1 colspan=12>Table 2 Precision / Reproducibility results of Pocguide™M Multi-Drug Test Panel</td></tr><tr><td rowspan=2 colspan=1>Drug testedClaimed Cutoff</td><td rowspan=2 colspan=1>%cutoff</td><td rowspan=1 colspan=2>Lot 1</td><td rowspan=1 colspan=2>Lot 2</td><td rowspan=1 colspan=2>Lot 3</td><td rowspan=1 colspan=2>Total Result</td><td rowspan=2 colspan=1>%Positive</td><td rowspan=2 colspan=1>%Negative</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=9 colspan=1>AMP500</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>123</td><td rowspan=1 colspan=1>27</td><td rowspan=1 colspan=1>82.0%</td><td rowspan=1 colspan=1>18.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>AMP1000</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>85.3%</td><td rowspan=1 colspan=1>14.7%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>BUP10</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>BAR300</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>82.7%</td><td rowspan=1 colspan=1>17.3%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>BZO300</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>COC300</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr></table>

Aicheck Biotech, Inc.   

<table><tr><td rowspan=1 colspan=12>17701 Cowan Ste 230, Irvine, CA, USA, 92614</td></tr><tr><td rowspan=2 colspan=1>Drug testedClaimed Cutoff</td><td rowspan=1 colspan=1>%cutoff</td><td rowspan=1 colspan=2>Lot 1</td><td rowspan=1 colspan=2>Lot 2</td><td rowspan=1 colspan=2>Lot 3</td><td rowspan=1 colspan=2>Total Result</td><td rowspan=1 colspan=1>%Positive</td><td rowspan=2 colspan=1>%Negative</td></tr><tr><td rowspan=1 colspan=1>%cutoff</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>%Positive</td></tr><tr><td rowspan=9 colspan=1>C150</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>82.7%</td><td rowspan=1 colspan=1>17.3%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>EDDP300</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>85.3%</td><td rowspan=1 colspan=1>14.7%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>MET1000</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>122</td><td rowspan=1 colspan=1>28</td><td rowspan=1 colspan=1>81.3%</td><td rowspan=1 colspan=1>18.7%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>MET500</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>MDMA500</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>OPI2000</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=8 colspan=1>MOP300</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>124</td><td rowspan=1 colspan=1>26</td><td rowspan=1 colspan=1>82.7%</td><td rowspan=1 colspan=1>17.3%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr></table>

Aicheck Biotech, Inc. 17701 Cowan Ste 230, Irvine, CA, USA, 92614   

<table><tr><td rowspan=2 colspan=1>Drug testedClaimed Cutoff</td><td rowspan=2 colspan=1>%cutoff</td><td rowspan=1 colspan=2>Lot 1</td><td rowspan=1 colspan=2>Lot 2</td><td rowspan=1 colspan=2>Lot 3</td><td rowspan=1 colspan=2>Total Result</td><td rowspan=2 colspan=1>%Positive</td><td rowspan=2 colspan=1>%Negative</td></tr><tr><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>MTD300</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>127</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>84.7%</td><td rowspan=1 colspan=1>15.3%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>OXY100</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>130</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>86.7%</td><td rowspan=1 colspan=1>13.3%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>PCP25</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>127</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>84.7%</td><td rowspan=1 colspan=1>15.3%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>TCA1000</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>126</td><td rowspan=1 colspan=1>24</td><td rowspan=1 colspan=1>84.0%</td><td rowspan=1 colspan=1>16.0%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=9 colspan=1>THC50</td><td rowspan=1 colspan=1>+100% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+75% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+50% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>+25% cutoff</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100.0%</td><td rowspan=1 colspan=1>0.0%</td></tr><tr><td rowspan=1 colspan=1>cutoff</td><td rowspan=1 colspan=1>42</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>128</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>85.3%</td><td rowspan=1 colspan=1>14.7%</td></tr><tr><td rowspan=1 colspan=1>-25% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-50% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-75% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr><tr><td rowspan=1 colspan=1>-100% cutoff</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0.0%</td><td rowspan=1 colspan=1>100.0%</td></tr></table>

# b Linearity/assay reportable range

Linearity is not applicable since this is a qualitative test.

# c Analytical specificity/Interference

# c.1 Cross-Reactivity

To test cross-reactivity, drug metabolites and other structurally related compounds that are likely to cross-react in urine samples were spiked into drug-free urine sample and were tested using three lots of each device. The lowest concentration that caused a positive result for each compound is listed below along with the corresponding $\%$ crossreactivity. The highest concentration tested is shown if no cross reactivity was observed.

Table 3 Cross-Reactivity results of PocguideTM Multi-Drug Test Panel   

<table><tr><td colspan="1" rowspan="1">Drug (Cutoff)</td><td colspan="1" rowspan="1">Substances</td><td colspan="1" rowspan="1">Minimum concentration requiredto obtain a positive result (ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="4">AMP 500</td><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">l-Amphetamine</td><td colspan="1" rowspan="1">15000</td><td colspan="1" rowspan="1">3.30%</td></tr><tr><td colspan="1" rowspan="1">dl- Amphetamine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">33.30%</td></tr><tr><td colspan="1" rowspan="1">(+/-) 3,4-Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="40">AMP 1000</td><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">33.30%</td></tr><tr><td colspan="1" rowspan="1">Hydroxyamphetamine</td><td colspan="1" rowspan="1">8000</td><td colspan="1" rowspan="1">6.25%</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">cYm</td></tr><tr><td colspan="1" rowspan="1">(+/-) 3,4-Methylenedioxyethylamphetamine (MDE)</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(+/-) 3,4-Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">β-Phenylethylamine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.50%</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.50%</td></tr><tr><td colspan="1" rowspan="1">p-Hydroxynorephedrine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.50%</td></tr><tr><td colspan="1" rowspan="1">Phenylpropanolamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(±) Phenylpropanolamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">p-Hydroxyamphetamine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.50%</td></tr><tr><td colspan="1" rowspan="1">d/1-Norephedrine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.50%</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">1-Ephedrine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">cYm</td></tr><tr><td colspan="1" rowspan="1">1-Epinephrine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">cYm</td></tr><tr><td colspan="1" rowspan="1">d/1-Epinephrine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">d-Amphetamine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">30000</td><td colspan="1" rowspan="1">3.30%</td></tr><tr><td colspan="1" rowspan="1">dl- Amphetamine</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">33.30%</td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">20%</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">33.30%</td></tr><tr><td colspan="1" rowspan="1">Hydroxyamphetamine</td><td colspan="1" rowspan="1">8000</td><td colspan="1" rowspan="1">12.50%</td></tr><tr><td colspan="1" rowspan="1">d-Methamphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxyethylamphetamine (MDEA)</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ephedrine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">β-Phenylethylamine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">p-Hydroxynorephedrine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">Phenylpropanolamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(±) Phenylpropanolamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">p-Hydroxyamphetamine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">d/l-Norephedrine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">1-Ephedrine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">1-Epinephrine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">d/1-Epinephrine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="7">BUP 10</td><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine -3-D-Glucuronide</td><td colspan="1" rowspan="1">15</td><td colspan="1" rowspan="1">66.67%</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Norbuprenorphine-3-D-Glucuronide</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="10">BAR 300</td><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">6%</td></tr><tr><td colspan="1" rowspan="1">Alphenol</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">Aprobarbital</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150%</td></tr><tr><td colspan="1" rowspan="1">Butabarbital</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200%</td></tr><tr><td colspan="1" rowspan="1">Butethal</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">600%</td></tr><tr><td colspan="1" rowspan="1">Butalbital</td><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">12%</td></tr><tr><td colspan="1" rowspan="1">Cyclopentobarbital</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Pentobarbital</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">15%</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">6%</td></tr><tr><td colspan="1" rowspan="5">BZO 300</td><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Alprazolam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150%</td></tr><tr><td colspan="1" rowspan="1">a-Hydroxyalprazolam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Bromazepam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20%</td></tr></table>

Aicheck Biotech, Inc. 17701 Cowan Ste 230, Irvine, CA, USA, 92614   

<table><tr><td colspan="1" rowspan="1">Drug (Cutoff)</td><td colspan="1" rowspan="1">Substances</td><td colspan="1" rowspan="1">Minimum concentration requiredto obtain a positive result (ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="17"></td><td colspan="1" rowspan="1">Clobazam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Clonazepam</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">10%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Clorazepate dipotassium</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Delorazepam</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Desalkylfurazepam</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">75%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Estazolam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Flunitrazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Midazolam</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">6%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Nitrazepam</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Norchlordiazepoxide</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">150%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Temazepam</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">120%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Triazolam</td><td colspan="1" rowspan="1">1200</td><td colspan="1" rowspan="1">25%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Demoxepam</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">15%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Flurazepam</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">60%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">D, L-Lorazepam</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">20%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="6">COC 300</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Cocaethylene</td><td colspan="1" rowspan="1">15000</td><td colspan="1" rowspan="1">2%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">30000</td><td colspan="1" rowspan="1">1%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">-</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Norcocaine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="6">COC 150</td><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Cocaine</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">30%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Cocaethylene</td><td colspan="1" rowspan="1">6250</td><td colspan="1" rowspan="1">2.40%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ecgonine</td><td colspan="1" rowspan="1">16000</td><td colspan="1" rowspan="1">0.94%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">--</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Norcocaine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="7">EDDP 300</td><td colspan="1" rowspan="1">2-ethylidene-1,5-dimethyl-3,-diphenylpyrolidi</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">200000</td><td colspan="1" rowspan="1">0.15%</td><td></td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">300000</td><td colspan="1" rowspan="1">0.10%</td><td></td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">Disopyramide</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">LAAM (Levo-alpha-acetymthadol) HCI</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">Alpha Methadol</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">--</td><td></td></tr><tr><td colspan="1" rowspan="26">MET 1000MET 500</td><td colspan="1" rowspan="1">D (+)-Methamphetamine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td><td></td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxy-n-ethylamphetamine (MDEA)</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">50%</td><td></td></tr><tr><td colspan="1" rowspan="1">D/L-Methamphetamine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td><td></td></tr><tr><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">30000</td><td colspan="1" rowspan="1">3.30%</td><td></td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">20000</td><td colspan="1" rowspan="1">5%</td><td></td></tr><tr><td colspan="1" rowspan="1">(+/-) -Ephedrine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">2%</td><td></td></tr><tr><td colspan="1" rowspan="1">(-) -Methamphetamine</td><td colspan="1" rowspan="1">25000</td><td colspan="1" rowspan="1">4%</td><td></td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">2500</td><td colspan="1" rowspan="1">40%</td><td></td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">4000</td><td colspan="1" rowspan="1">25%</td><td></td></tr><tr><td colspan="1" rowspan="1">β-Phenylethylamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">2%</td><td></td></tr><tr><td colspan="1" rowspan="1">Trimethobenzamide</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">10%</td><td></td></tr><tr><td colspan="1" rowspan="1">d,l-Amphetamine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">1%</td><td></td></tr><tr><td colspan="1" rowspan="1">Mephetermine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">2%</td><td></td></tr><tr><td colspan="1" rowspan="1">(1R,2S)-(-)-Ephedrine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">1-phenylephrine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1"></td><td></td></tr><tr><td colspan="1" rowspan="1">L-Methamphetamine</td><td colspan="1" rowspan="1">20000</td><td colspan="1" rowspan="1">5%</td><td></td></tr><tr><td colspan="1" rowspan="1">D (+) -Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td><td></td></tr><tr><td colspan="1" rowspan="1">(+/-)3,4-Methylenedioxy-n-ethylamphetamine (MDEA)</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">25%</td><td></td></tr><tr><td colspan="1" rowspan="1">D/L-Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td><td></td></tr><tr><td colspan="1" rowspan="1">p-Hydroxymethamphetamine</td><td colspan="1" rowspan="1">15000</td><td colspan="1" rowspan="1">3.33%%</td><td></td></tr><tr><td colspan="1" rowspan="1">D-Amphetamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">1%</td><td></td></tr><tr><td colspan="1" rowspan="1">L-Amphetamine</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">0.50%</td><td></td></tr><tr><td colspan="1" rowspan="1">Chloroquine</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">5%</td><td></td></tr><tr><td colspan="1" rowspan="1">(+/-)-Ephedrine</td><td colspan="1" rowspan="1">25000</td><td colspan="2" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Drug (Cutoff)</td><td colspan="1" rowspan="1">Substances</td><td colspan="1" rowspan="1">Minimum concentration requiredto obtain a positive result (ng/mL)</td><td colspan="1" rowspan="1">% Cross-Reactivity</td></tr><tr><td colspan="1" rowspan="10"></td><td colspan="1" rowspan="1">(-)-Methamphetamine</td><td colspan="1" rowspan="1">12500</td><td colspan="1" rowspan="1">4%</td></tr><tr><td colspan="1" rowspan="1">(+/-4-ethylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(+/-3,4-ethylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">β-Phenylethylamine</td><td colspan="1" rowspan="1">25000</td><td colspan="1" rowspan="1">2%</td></tr><tr><td colspan="1" rowspan="1">Trimethobenzamide</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">d,I-Amphetamine</td><td colspan="1" rowspan="1">75000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Mephetermine</td><td colspan="1" rowspan="1">25000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">(1R,2S)- (-)-Ephedrine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">1-phenylephrine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">L-Methamphetamine</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">5%</td></tr><tr><td colspan="1" rowspan="7">MDMA 500</td><td colspan="1" rowspan="1">3,4-Methylenedioxymethamphetamine (MDMA)</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyamphetamine HCI (MDA)</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">16.67%</td></tr><tr><td colspan="1" rowspan="1">3,4-Methylenedioxyethylamphetamine (MDEA)</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">d-methamphetamine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">d-amphetamine</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">1-methamphetamine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">1-amphetamine</td><td colspan="1" rowspan="1">&gt;10000</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="16">OPI 2000</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">50000</td><td colspan="1" rowspan="1">4%</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">s-MonoacetylImorphine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100%%%</td></tr><tr><td colspan="1" rowspan="1">Ethyl Morphine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">133.30%</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">12500</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">3500</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Morphinie-3-β-d-glucuronide</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">25000</td><td colspan="1" rowspan="1">8%</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">25000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1"> Thhebaine</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">75000</td><td colspan="1" rowspan="1">2.70%</td></tr><tr><td colspan="1" rowspan="1">6-Monoacetylmorphine (6-MAM)</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">133.30%</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">12500</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">1500000</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="16">MOP 300</td><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">120%</td></tr><tr><td colspan="1" rowspan="1"> Codeine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">s-Monoacetylmorphine</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Ethyl Morphine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">300%</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">6%</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">15%</td></tr><tr><td colspan="1" rowspan="1">Morphinie-3-βd-glucuronide</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">30%</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">0.30%</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">6%</td></tr><tr><td colspan="1" rowspan="1">6-Monoacetylmorphine (6-MAM)</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">200%lo</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">4.60%</td></tr><tr><td colspan="1" rowspan="1">Procaine</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">0.30%</td></tr><tr><td colspan="1" rowspan="6">MTD 300</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Doxylamine</td><td colspan="1" rowspan="1">3000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">EDD</td><td colspan="1" rowspan="1">&gt; 10000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">EMD P</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">LAAM</td><td colspan="1" rowspan="1">&gt; 10000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">Alpha Methadol</td><td colspan="1" rowspan="1">&gt; 100000</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="7">OXY 100</td><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">20000</td><td colspan="1" rowspan="1">0.50%</td></tr><tr><td colspan="1" rowspan="1">Hydroocodone</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">Oxymrphone</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.10%</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">32000</td><td colspan="1" rowspan="1">0.30%</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">-</td></tr><tr><td colspan="1" rowspan="4"></td><td colspan="1" rowspan="1">Acetylmorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">Ethylmorphine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="1">Thebaine</td><td colspan="1" rowspan="1">&gt;100000</td><td colspan="1" rowspan="1">--</td></tr><tr><td colspan="1" rowspan="2">PCP 25</td><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">4-Hydroxyphencyclidine</td><td colspan="1" rowspan="1">12500</td><td colspan="1" rowspan="1">0.20%</td></tr><tr><td colspan="1" rowspan="13">TCA 1000</td><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Nordoxepine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Trimipramine</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">66.70%</td></tr><tr><td colspan="1" rowspan="1">Promazine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">66.70%</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">250%</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">250%</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">12500</td><td colspan="1" rowspan="1">8%</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">Maprotiline</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">25000</td><td colspan="1" rowspan="1">4%</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">66.70%</td></tr><tr><td colspan="1" rowspan="1">Norclomipramine</td><td colspan="1" rowspan="1">10000</td><td colspan="1" rowspan="1">10%</td></tr><tr><td colspan="1" rowspan="9">THC 50</td><td colspan="1" rowspan="1">11-nor-Δ9-THC-9-COOH</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">(-)-11-nor-9-carboxy-∆9-THC</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="1">11-nor-Δ8-THC-9-COOH</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">166.67%</td></tr><tr><td colspan="1" rowspan="1">11-nor-∆9-THC-carboxy glucuronide</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">50%</td></tr><tr><td colspan="1" rowspan="1">Cannabinol</td><td colspan="1" rowspan="1">20000</td><td colspan="1" rowspan="1">0.25%</td></tr><tr><td colspan="1" rowspan="1">Cannabidiol</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">0.05%</td></tr><tr><td colspan="1" rowspan="1">Δ8- Tetrahydrocannabinol</td><td colspan="1" rowspan="1">1300</td><td colspan="1" rowspan="1">3.80%</td></tr><tr><td colspan="1" rowspan="1">Δ9- Tetrahydrocannabinol</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">1%</td></tr><tr><td colspan="1" rowspan="1">511-hydroxy-∆9-Tetrahydrocannabinol</td><td colspan="1" rowspan="1">5000</td><td colspan="1" rowspan="1">1%</td></tr></table>

# c.2 Interference Study

otential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and urine samples with concentrations of the target drugs at $2 5 \%$ below and $2 5 \%$ above Cutoff levels. These urine samples were tested using three lots of each device. The compounds were tested at $1 0 0 ~ { \mu \mathrm { g / m L } }$ (unless therwise noted in the table). No interference was observed for any of the compounds tested, and the list of compounds is provided in the following table.

Table 4 Interfering substances   

<table><tr><td rowspan=1 colspan=1>Acetaminophen</td><td rowspan=1 colspan=1>Ciprofloxacin Hydrochloride</td><td rowspan=1 colspan=1>1% Ethanol</td><td rowspan=1 colspan=1>Lidocaine Hydrochloride</td><td rowspan=1 colspan=1>Ondansetran</td></tr><tr><td rowspan=1 colspan=1>Acetophenetidin</td><td rowspan=1 colspan=1>Citalopram</td><td rowspan=1 colspan=1>Fenofibrate</td><td rowspan=1 colspan=1>Lisinopril</td><td rowspan=1 colspan=1>Paliperidone</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid</td><td rowspan=1 colspan=1>Clarithromycin</td><td rowspan=1 colspan=1>Fenoprofen</td><td rowspan=1 colspan=1>Lithium Carbonate</td><td rowspan=1 colspan=1>Pantoprazole</td></tr><tr><td rowspan=1 colspan=1>Acyclovir</td><td rowspan=1 colspan=1>Clonidine</td><td rowspan=1 colspan=1>Fentanyl Citrate</td><td rowspan=1 colspan=1>Liverite</td><td rowspan=1 colspan=1>Papaverine</td></tr><tr><td rowspan=1 colspan=1>Afrin</td><td rowspan=1 colspan=1>Clopidogrel Hydrogen Sulphate</td><td rowspan=1 colspan=1>Fluoxetine Hydrochloride</td><td rowspan=1 colspan=1>Loperamide</td><td rowspan=1 colspan=1>Paroxetine Hydrochloride</td></tr><tr><td rowspan=1 colspan=1>Albumin(100mg/dL)</td><td rowspan=1 colspan=1>Clozapine</td><td rowspan=1 colspan=1>Fluvoxamine</td><td rowspan=1 colspan=1>Loratadine</td><td rowspan=1 colspan=1>Penfluridol</td></tr><tr><td rowspan=1 colspan=1>Aminophylline</td><td rowspan=1 colspan=1>Conjugated Estrogens</td><td rowspan=1 colspan=1>Furosemide</td><td rowspan=1 colspan=1>Magnesium</td><td rowspan=1 colspan=1>PenicillinV Potassium</td></tr><tr><td rowspan=1 colspan=1>Aminopyrine</td><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>Gabapentin</td><td rowspan=1 colspan=1>Meperidine</td><td rowspan=1 colspan=1>Penicillin-G</td></tr><tr><td rowspan=1 colspan=1>Amiodarone Hydrochloride</td><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Gentisic Acid</td><td rowspan=1 colspan=1>Meprobamate</td><td rowspan=1 colspan=1>Phenelzine</td></tr><tr><td rowspan=1 colspan=1>Amlodipine Mesylate</td><td rowspan=1 colspan=1>(-) Cotinine</td><td rowspan=1 colspan=1>Glibenclamide</td><td rowspan=1 colspan=1>Metoprolol Tartrate</td><td rowspan=1 colspan=1>Pioglitazone Hydrochloride</td></tr><tr><td rowspan=1 colspan=1>Amoxicillin</td><td rowspan=1 colspan=1>chlorpheniramine</td><td rowspan=1 colspan=1>Gliclazide</td><td rowspan=1 colspan=1>Mifepristone</td><td rowspan=1 colspan=1>Piracetam</td></tr><tr><td rowspan=1 colspan=1>Ampicillin</td><td rowspan=1 colspan=1>D, L-Octopamine</td><td rowspan=1 colspan=1>Glipizide</td><td rowspan=1 colspan=1>Mirtazapine</td><td rowspan=1 colspan=1>Pravastatin Sodium</td></tr><tr><td rowspan=1 colspan=1>Apomorphine</td><td rowspan=1 colspan=1>D, L-Propranolol</td><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>Montelukast Sodium</td><td rowspan=1 colspan=1>Prednisone</td></tr><tr><td rowspan=1 colspan=1>Aripiprazole</td><td rowspan=1 colspan=1>D, L-Tyrosine</td><td rowspan=1 colspan=1>Haloperidol</td><td rowspan=1 colspan=1>Mosapride Citrate</td><td rowspan=1 colspan=1>Propylthiouracil</td></tr><tr><td rowspan=1 colspan=1>Aspartame</td><td rowspan=1 colspan=1>Deoxy- corticosterone</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Minocycline</td><td rowspan=1 colspan=1>Quetiapine Fumarate</td></tr><tr><td rowspan=1 colspan=1>Atomoxetine</td><td rowspan=1 colspan=1>Dextromethorphan</td><td rowspan=1 colspan=1>Hydrochlorothiazide</td><td rowspan=1 colspan=1>Nalidixic Acid</td><td rowspan=1 colspan=1>Quinine</td></tr><tr><td rowspan=1 colspan=1>Atorvastatin Calcium</td><td rowspan=1 colspan=1>Diclofenac</td><td rowspan=1 colspan=1>Hydrocortisone</td><td rowspan=1 colspan=1>Naproxen</td><td rowspan=1 colspan=1>Ranitidine</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>Diflunisal</td><td rowspan=1 colspan=1>3-Hydroxytyramine</td><td rowspan=1 colspan=1>Niacinamide</td><td rowspan=1 colspan=1>Rifampicin</td></tr><tr><td rowspan=1 colspan=1>Benzilic Acid</td><td rowspan=1 colspan=1>Digoxin</td><td rowspan=1 colspan=1>Isosorbide Dinitrate</td><td rowspan=1 colspan=1>Nifedipine</td><td rowspan=1 colspan=1>Risperidone</td></tr><tr><td rowspan=1 colspan=1>Benzoic Acid</td><td rowspan=1 colspan=1>Diphenhydramine</td><td rowspan=1 colspan=1>Isoxsuprine</td><td rowspan=1 colspan=1>Nikethamide</td><td rowspan=1 colspan=1>Salicylic Acid</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Dirithromycin</td><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>Nimodipine</td><td rowspan=1 colspan=1>Serotonin</td></tr><tr><td rowspan=1 colspan=1>Bupropion</td><td rowspan=1 colspan=1>Domperidone</td><td rowspan=1 colspan=1>Ketoconazole</td><td rowspan=1 colspan=1>Nitroglycerin</td><td rowspan=1 colspan=1>Sertraline Hydrochloride</td></tr><tr><td rowspan=1 colspan=1>Captopril</td><td rowspan=1 colspan=1>D-Pseudoephedrine</td><td rowspan=1 colspan=1>Ketoprofen</td><td rowspan=1 colspan=1>Norethindrone</td><td rowspan=1 colspan=1>Sildenafil Citrate</td></tr><tr><td rowspan=1 colspan=1>Carbamazepine</td><td rowspan=1 colspan=1>Duloxetine</td><td rowspan=1 colspan=1>Ketamine</td><td rowspan=1 colspan=1>N-Acetylprocain-amide</td><td rowspan=1 colspan=1>Simvastatin</td></tr><tr><td rowspan=1 colspan=1>Cefradine</td><td rowspan=1 colspan=1>Dicyclomine</td><td rowspan=1 colspan=1>Kratom powder</td><td rowspan=1 colspan=1>O-Hydroxyhippuric Acid</td><td rowspan=1 colspan=1>Sodium Valproate</td></tr><tr><td rowspan=1 colspan=1>Cephalexin</td><td rowspan=1 colspan=1>Effexor</td><td rowspan=1 colspan=1>Labetalol</td><td rowspan=1 colspan=1>Olanzapine</td><td rowspan=1 colspan=1>Spironolactone</td></tr><tr><td rowspan=1 colspan=1>Chloral Hydrate</td><td rowspan=1 colspan=1>Enalapril Maleate</td><td rowspan=1 colspan=1>Lamotrigine</td><td rowspan=1 colspan=1>Omeprazole</td><td rowspan=1 colspan=1>Sulfamethazine</td></tr><tr><td rowspan=1 colspan=1>Chloramphenicol</td><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>Levofloxacin Hydrochloride</td><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>Sulindac</td></tr></table>

Aicheck Biotech, Inc. 17701 Cowan Ste 230, Irvine, CA, USA, 92614   

<table><tr><td rowspan=1 colspan=1>Chlorothiazide</td><td rowspan=1 colspan=1>Esomeprazole Magnesium</td><td rowspan=1 colspan=1>Levonorgestrel</td><td rowspan=1 colspan=1>Oxolinic Acid</td><td rowspan=1 colspan=1>Tetracycline</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>β-Estradiol</td><td rowspan=1 colspan=1>Levothyroxine Sodium</td><td rowspan=1 colspan=1>Oxymetazoline</td><td rowspan=1 colspan=1>Tetrahydrocortsone 3 -acetate</td></tr><tr><td rowspan=1 colspan=1>Tetrahydrocortisone 3-(β-D glucuronide)</td><td rowspan=1 colspan=1>Thioridazine</td><td rowspan=1 colspan=1>Trazodone Hydrochloride</td><td rowspan=1 colspan=1>Trimethoprim</td><td rowspan=1 colspan=1>Verapamil</td></tr><tr><td rowspan=1 colspan=1>Tetrahydrozoline</td><td rowspan=1 colspan=1>Topiramate</td><td rowspan=1 colspan=1>Triamterene</td><td rowspan=1 colspan=1>Uric Acid</td><td rowspan=1 colspan=1>Vitamin B2</td></tr><tr><td rowspan=1 colspan=1>Thiamine</td><td rowspan=1 colspan=1>Tramadol Hydrochloride</td><td rowspan=1 colspan=1>Trifluoperazine</td><td rowspan=1 colspan=1>Valproate</td><td rowspan=1 colspan=1>Vitamin C</td></tr><tr><td rowspan=1 colspan=1>Chloroquine</td><td rowspan=1 colspan=1>Ecgonine Methyl Ester</td><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>Epinephrine Hydrochloride</td><td rowspan=1 colspan=1>Maprotiline</td></tr><tr><td rowspan=1 colspan=1>Promethazine</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr></table>

c.3 Effect of urine specific gravity and pH

To investigate the effect of urine specific gravity and urine pH, urine samples, with specific gravity ranging from 1.000 to 1.035 or urine samples with pH ranging from 4 to 9 were spiked with the target drugs to concentrations at - ${ \cdot } 2 5 \%$ Cutoff and $+ 2 5 \%$ Cutoff levels. These samples were tested using three lots of each device. Results were all positive for samples at $+ 2 5 \%$ Cutoff and all negative for samples at $- 2 5 \%$ Cutoff. The results demonstrated that urine specific gravity levels of 1.000 to 1.035 and urine pH levels of 4 to 9 do not affect the results of the assays.

# d Traceability, Stability, Expected values (controls, calibrators, or methods):

# d.1 Traceability

The device is traceable to commercially available materials.

d.2 Stability

The stability data supports that the products have the shelf life of 24 months when stored at 4 $- 3 0 \mathrm { { ^ \circ C } }$

# Real time Stability

A 27-month real time stability test is planned to verify the shelf-life stability of the device as 24 months. Three batches for each configuration in sealed foil pouch are currently stable for 21 months at $4 ^ { \circ } \mathrm { C }$ and $3 0 ^ { \circ } \mathrm { C }$ , and the real time stability study is still on-going.

# Accelerated Stability

Stable at $4 { - } 3 0 ^ { \circ } \mathrm { C }$ for 24 months based on the accelerated stability study at $5 5 ^ { \circ } \mathrm { C }$ for 31 days and real time stability determination at both $4 ^ { \circ } \mathrm { C }$ and $3 0 ^ { \circ } \mathrm { C }$ .

# e Detection limit

Not Applicable.

# Assay Cut-off

Refer to section 9.1.a.

# 9.2 Comparison Studies

# a Method comparison studies

Method comparison studies were performed by three operators. Eighty (80) unaltered clinical samples (40 negative and 40 positive) were run for each target drug. The samples were tested in a blinded fashion and compared to LC/MS results. The results are presented in Table 5 below, and the discordant results are summarized in below.

Table 5 The Results of Method comparison with predicate device   

<table><tr><td rowspan=1 colspan=1>Drugcutoff</td><td rowspan=1 colspan=2>Candidate Device Result</td><td rowspan=1 colspan=1>Drug-Free</td><td rowspan=1 colspan=1>Low Negative by LC/MS(less than - 50%)</td><td rowspan=1 colspan=1>Near Cutoff Negative by LC/MS(Between -50% and cutoff)</td><td rowspan=1 colspan=1>Near Cutoff Positive by LC/MS(Between cutoff and +50%)</td><td rowspan=1 colspan=1>High Positive by LC/MS(greater than +50%)</td></tr><tr><td rowspan=6 colspan=1>AMP 1000</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>AMP 500</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>23</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>23</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>23</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>BAR 300</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>19</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>BUP 10</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>BZO 300</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>COC 300</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>21</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=4 colspan=1>COC 150</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Aicheck Biotech, Inc. 17701 Cowan Ste 230, Irvine, CA, USA, 92614   

<table><tr><td rowspan=2 colspan=1>Drugcutoff</td><td rowspan=2 colspan=2>Candidate Device Result</td><td rowspan=2 colspan=1>Drug-Free</td><td rowspan=2 colspan=1>Low Negative by LC/MS(less than - 50%)</td><td rowspan=2 colspan=1>Near Cutoff Negative by LC/MS(Between -50% and cutoff)</td><td rowspan=1 colspan=1>Near Cutoff Positive by LC/MS</td><td rowspan=2 colspan=1>High Positive by LC/MS(greater than +50%)</td></tr><tr><td rowspan=1 colspan=1>(Between cutoff and +50%)</td></tr><tr><td rowspan=2 colspan=1></td><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>EDDP 300</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>MET 1000</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>22</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>MET 500</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>16</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>16</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>16</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>OPI 2000</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>MOP 300</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>MTD 300</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>24</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>OXY 100</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>23</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>15</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>PCP 25</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>TCA 1000</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>THC 50</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>17</td><td rowspan=1 colspan=1>20</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=6 colspan=1>MDMA 500</td><td rowspan=2 colspan=1>Viewer A</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer B</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>Viewer C</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Table 6 Discordant results   

<table><tr><td rowspan=1 colspan=1>Drug cutoff</td><td rowspan=1 colspan=1>Operator</td><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>LC/MS Results(ng/mL)</td><td rowspan=1 colspan=1>Test Result</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Drug cutoff</td><td rowspan=1 colspan=1>Operator</td><td rowspan=1 colspan=1>Sample ID</td><td rowspan=1 colspan=1>LC/MS Results(ng/mL)</td><td rowspan=1 colspan=1>Test Result</td></tr><tr><td rowspan=3 colspan=1>AMP 1000</td><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>AH621</td><td rowspan=1 colspan=1>968.6</td><td rowspan=1 colspan=1>Positive</td><td rowspan=4 colspan=1></td><td rowspan=6 colspan=1>MET 500</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>ML217</td><td rowspan=1 colspan=1>457.3</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>AH618</td><td rowspan=1 colspan=1>970.1</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>ML177</td><td rowspan=1 colspan=1>491</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>AH562</td><td rowspan=1 colspan=1>1101</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>ML224</td><td rowspan=1 colspan=1>506</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=6 colspan=1>AMP 500</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>AL554</td><td rowspan=1 colspan=1>472.6</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>ML216</td><td rowspan=1 colspan=1>512</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>AL486</td><td rowspan=1 colspan=1>475.7</td><td rowspan=1 colspan=1>Positive</td><td rowspan=2 colspan=1></td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>ML168</td><td rowspan=1 colspan=1>518</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>AL546</td><td rowspan=1 colspan=1>489</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>ML233</td><td rowspan=1 colspan=1>523</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>AL491</td><td rowspan=1 colspan=1>501.2</td><td rowspan=1 colspan=1>Negative</td><td rowspan=4 colspan=1></td><td rowspan=4 colspan=1>OPI 2000</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>OP094</td><td rowspan=1 colspan=1>1869.3</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>AL551</td><td rowspan=1 colspan=1>508.9</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>OP084</td><td rowspan=1 colspan=1>1983</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>AL483</td><td rowspan=1 colspan=1>536.2</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>OP149</td><td rowspan=1 colspan=1>2045</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=4 colspan=1>BAR 300</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BA436</td><td rowspan=1 colspan=1>296</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>OP087</td><td rowspan=1 colspan=1>2080</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>BA445</td><td rowspan=1 colspan=1>302.1</td><td rowspan=1 colspan=1>Negative</td><td rowspan=5 colspan=1></td><td rowspan=5 colspan=1>MOP 300</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>M0033</td><td rowspan=1 colspan=1>287.5</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BA474</td><td rowspan=1 colspan=1>307.2</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>M0039</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BA403</td><td rowspan=1 colspan=1>319.83</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>M0028</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=5 colspan=1>BUP 10</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>BU001</td><td rowspan=1 colspan=1>8.36</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>M0009</td><td rowspan=1 colspan=1>301.6</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BU052</td><td rowspan=1 colspan=1>9.21</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>M0071</td><td rowspan=1 colspan=1>319.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BU053</td><td rowspan=1 colspan=1>9.42</td><td rowspan=1 colspan=1>Positive</td><td rowspan=7 colspan=1></td><td rowspan=7 colspan=1>OXY 100</td><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>0X236</td><td rowspan=1 colspan=1>87</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BU007</td><td rowspan=1 colspan=1>10.2</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OX228</td><td rowspan=1 colspan=1>92.3</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BU003</td><td rowspan=1 colspan=1>10.5</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>OX204</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=7 colspan=1>BZO 300</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>BZ100</td><td rowspan=1 colspan=1>282</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>0X185</td><td rowspan=1 colspan=1>96</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>BZ112</td><td rowspan=1 colspan=1>291.2</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>0X199</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BZ149</td><td rowspan=1 colspan=1>298</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>0X209</td><td rowspan=1 colspan=1>102</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>BZ103</td><td rowspan=1 colspan=1>301</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>OX195</td><td rowspan=1 colspan=1>103</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>BZ096</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td><td rowspan=4 colspan=1></td><td rowspan=4 colspan=1>PCP 25</td><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>PC252</td><td rowspan=1 colspan=1>23.16</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>BZ108</td><td rowspan=1 colspan=1>309</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>PC260</td><td rowspan=1 colspan=1>23.97</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>BZ155</td><td rowspan=1 colspan=1>317.6</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>PC286</td><td rowspan=1 colspan=1>25.39</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=3 colspan=1>COC300</td><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>CH945</td><td rowspan=1 colspan=1>294.8</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>PC297</td><td rowspan=1 colspan=1>25.9</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>CH948</td><td rowspan=1 colspan=1>328.5</td><td rowspan=1 colspan=1>Negative</td><td rowspan=7 colspan=1></td><td rowspan=7 colspan=1>TCA 1000</td><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>TA752</td><td rowspan=1 colspan=1>849</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>CH893</td><td rowspan=1 colspan=1>338.5</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>TA776</td><td rowspan=1 colspan=1>892</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=6 colspan=1>COC 150</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>CL801</td><td rowspan=1 colspan=1>145</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>TA724</td><td rowspan=1 colspan=1>934</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>CL827</td><td rowspan=1 colspan=1>154</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>TA774</td><td rowspan=1 colspan=1>1025</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>CL806</td><td rowspan=1 colspan=1>156</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>TA761</td><td rowspan=1 colspan=1>1058</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>CL839</td><td rowspan=1 colspan=1>159</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>TA767</td><td rowspan=1 colspan=1>1069</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>CL830</td><td rowspan=1 colspan=1>160.1</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>TA799</td><td rowspan=1 colspan=1>1079</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>CL858</td><td rowspan=1 colspan=1>163.5</td><td rowspan=1 colspan=1>Negative</td><td rowspan=5 colspan=1></td><td rowspan=5 colspan=1>THC 50</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>TH334</td><td rowspan=1 colspan=1>48</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=5 colspan=1>EDDP 300</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>ED366</td><td rowspan=1 colspan=1>280.8</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>TH375</td><td rowspan=1 colspan=1>48.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>ED350</td><td rowspan=1 colspan=1>281</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>TH374</td><td rowspan=1 colspan=1>50.35</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>ED335</td><td rowspan=1 colspan=1>284.1</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>TH339</td><td rowspan=1 colspan=1>53.46</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>ED331</td><td rowspan=1 colspan=1>325</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>TH398</td><td rowspan=1 colspan=1>54.45</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>ED358</td><td rowspan=1 colspan=1>335.7</td><td rowspan=1 colspan=1>Negative</td><td rowspan=5 colspan=1></td><td rowspan=5 colspan=1>MDMA 500</td><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>MD642</td><td rowspan=1 colspan=1>476.1</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=4 colspan=1>MET 1000</td><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>MH307</td><td rowspan=1 colspan=1>981.1</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>MD708</td><td rowspan=1 colspan=1>482.34</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>MH291</td><td rowspan=1 colspan=1>995.8</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>MD706</td><td rowspan=1 colspan=1>502</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>MH246</td><td rowspan=1 colspan=1>1039.7</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer B, C</td><td rowspan=1 colspan=1>MD681</td><td rowspan=1 colspan=1>527.89</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>MH302</td><td rowspan=1 colspan=1>1098</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>MD710</td><td rowspan=1 colspan=1>532</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=3 colspan=1>MTD 300</td><td rowspan=1 colspan=1>Viewer A, B</td><td rowspan=1 colspan=1>MT464</td><td rowspan=1 colspan=1>278.8</td><td rowspan=1 colspan=1>Positive</td><td rowspan=3 colspan=1></td><td rowspan=3 colspan=5></td></tr><tr><td rowspan=1 colspan=1>Viewer A, B, C</td><td rowspan=1 colspan=1>MT424</td><td rowspan=1 colspan=1>326.5</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A, C</td><td rowspan=1 colspan=1>MT475</td><td rowspan=1 colspan=1>329.8</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# b Matrix comparison

Not applicable. This device is for testing with human urine only.

10 Clinical studies

# a Clinical Sensitivity

Not applicable

# b Clinical specificity

Not applicable

# c Other clinical supportive data (when a. and b. are not applicable)

# c.1 Lay-User Study

The lay-user study was performed at three intended use sites. 58 male and 82 female tested PocguideTM Multi-Drug Test Panel Configuration 1 (including AMP 500, MET 500, MOP 300, COC 150); 56 male and 84 female tested PocguideTM Multi-Drug Test Panel Configuration 2 (including AMP 1000, MET 1000, MOP 2000 (OPI), COC 300). They had diverse educational and occupational backgrounds and their age range from 18 to $> 5 0$ . Urine samples were prepared at the following concentrations: - ${ \it \Omega } { \it 1 0 0 \% }$ , $+ / - 7 5 \% , + / \cdot$ - $5 0 \%$ , $+ / - 2 5 \%$ of the cutoff by spiking drug(s) into drug free-pooled urine specimens. The concentrations of the samples were confirmed by LC-MS/MS. Each sample was aliquoted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled sample and a device. The results are summarized in below.

Table 7 Result of PocguideTM Multi-Drug Test Panel Configuration 1 (including AMP 500, MET 500, MOP 300, COC 150)   

<table><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="2">Results</td><td colspan="7" rowspan="1">Concentration</td></tr><tr><td colspan="1" rowspan="1">(ng/mL)</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">+75% cutoff</td></tr><tr><td colspan="1" rowspan="4">AMP</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="2">BAR</td><td colspan="1" rowspan="2">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="2"></td><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BZO</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BUP</td><td colspan="1" rowspan="4">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">COC</td><td colspan="1" rowspan="4">150</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">EDDP</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MDMA</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MET</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MOP</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MTD</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">OXY</td><td colspan="1" rowspan="4">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">PCP</td><td colspan="1" rowspan="4">25</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">TCA</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">THC</td><td colspan="1" rowspan="4">50</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr></table>

Table 8 Result of PocguideTM Multi-Drug Test Panel Configuration 2 (including AMP 1000, MET 1000, MOP 2000 (OPI), COC 300)   

<table><tr><td colspan="1" rowspan="2">Drug</td><td colspan="1" rowspan="1">Cutoff</td><td colspan="1" rowspan="2">Results</td><td colspan="7" rowspan="1">Concentration</td></tr><tr><td colspan="1" rowspan="1">(ng/mL)</td><td colspan="1" rowspan="1">-100% cutoff</td><td colspan="1" rowspan="1">-75% cutoff</td><td colspan="1" rowspan="1">-50% cutoff</td><td colspan="1" rowspan="1">-25% cutoff</td><td colspan="1" rowspan="1">+25% cutoff</td><td colspan="1" rowspan="1">+50% cutoff</td><td colspan="1" rowspan="1">+75% cutoff</td></tr><tr><td colspan="1" rowspan="4">AMP</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BAR</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BZO</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">BUP</td><td colspan="1" rowspan="4">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">COC</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">EDDP</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MDMA</td><td colspan="1" rowspan="4">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MET</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">OPI</td><td colspan="1" rowspan="4">2000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">MTD</td><td colspan="1" rowspan="4">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">OXY</td><td colspan="1" rowspan="4">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">PCP</td><td colspan="1" rowspan="4">25</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">TCA</td><td colspan="1" rowspan="4">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr><tr><td colspan="1" rowspan="4">THC</td><td colspan="1" rowspan="4">50</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Total</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">20</td></tr><tr><td colspan="1" rowspan="1">Agreement (%)</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">95.00%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td><td colspan="1" rowspan="1">100%</td></tr></table>

Participants were given surveys on the ease of understanding the instruction for use. All participants indicated that the device instruction is easy to understand and follow. A Flesch-Kincaid reading analysis was performed on each package insert and the scores revealed a reading Grade Level of 7.

# d Clinical Cut-off

Not applicable

# 11 Conclusion

Based on the test principle and performance characteristics of the device including precision, cut-off, interference, specificity, method comparison and lay-user studies of the devices, it’s concluded that PocguideTM Multi-Drug Test Panel and PocguideTM Multi-Drug Test Panel OTC are substantially equivalent to the predicate devices. The submitted information in this premarket notification is complete and supports a substantial equivalence decision.